Hrt Financial LP Next Cure, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.7 - $9.1 $200,218 - $319,646
-35,126 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$6.74 - $8.02 $131,160 - $156,069
-19,460 Reduced 35.65%
35,126 $236,000
Q2 2021

Aug 16, 2021
BUY
$7.6 - $10.28 $133,121 - $180,064
17,516 Added 47.25%
54,586 $438,000
Q1 2021

May 17, 2021
BUY
$9.81 - $13.88 $363,656 - $514,531
37,070 New
37,070 $371,000

Others Institutions Holding NXTC

# of Institutions
44
Shares Held
15.9M
Call Options Held
0
Put Options Held
0
View Full List

About NextCure, Inc.

NXTC Quotes by TradingView
  • Ticker NXTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,748,800
  • Market Cap $36.4M
  • Description
  • NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...
More about NXTC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email